Truvestments Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $757K | Sell |
9,680
-478
| -5% | -$38.6K | 0.11% | 178 |
|
|
2026
Q1 | $880K | Sell |
10,158
-259
| -2% | -$24.8K | 0.16% | 149 |
|
|
2025
Q4 | $1M | Sell |
10,417
-195
| -2% | -$18.9K | 0.18% | 124 |
|
|
2025
Q3 | $1.01M | Sell |
10,612
-2,460
| -19% | -$226K | 0.18% | 121 |
|
|
2025
Q2 | $1.14M | Sell |
13,072
-1,038
| -7% | -$88K | 0.23% | 105 |
|
|
2025
Q1 | $1.27M | Sell |
14,110
-19,123
| -58% | -$1.71M | 0.28% | 78 |
|
|
2024
Q4 | $2.65M | Buy |
33,233
+1,706
| +5% | +$148K | 0.68% | 49 |
|
|
2024
Q3 | $2.84M | Buy |
31,527
+5,364
| +21% | +$451K | 0.76% | 42 |
|
|
2024
Q2 | $2.06M | Buy |
26,163
+1,526
| +6% | +$125K | 0.82% | 53 |
|
|
2024
Q1 | $2.15M | Buy |
24,637
+21,204
| +618% | +$1.81M | 0.83% | 47 |
|
|
2023
Q4 | $283K | Sell |
3,433
-992
| -22% | -$75.6K | 0.13% | 175 |
|
|
2023
Q3 | $347K | Sell |
4,425
-38
| -0.9% | -$3.18K | 0.18% | 109 |
|
|
2023
Q2 | $393K | Buy |
4,463
+21
| +0.5% | +$1.81K | 0.2% | 96 |
|
|
2023
Q1 | $358K | Sell |
4,442
-3,412
| -43% | -$278K | 0.19% | 97 |
|
|
2022
Q4 | $610K | Sell |
7,854
-14,968
| -66% | -$1.21M | 0.34% | 70 |
|
|
2022
Q3 | $1.84M | Buy |
22,822
+1,730
| +8% | +$155K | 1.16% | 31 |
|
|
2022
Q2 | $1.89M | Buy |
21,092
+1,346
| +7% | +$136K | 1.11% | 31 |
|
|
2022
Q1 | $2.19M | Buy |
19,746
+653
| +3% | +$69K | 1.2% | 28 |
|
|
2021
Q4 | $1.98M | Buy |
19,093
+382
| +2% | +$44.2K | 0.99% | 38 |
|
|
2021
Q3 | $2.35M | Buy |
18,711
+833
| +5% | +$108K | 1.29% | 18 |
|
|
2021
Q2 | $2.22M | Buy |
17,878
+2,132
| +14% | +$268K | 1.22% | 26 |
|
|
2021
Q1 | $1.86M | Buy |
15,746
+3,457
| +28% | +$405K | 1.05% | 24 |
|
|
2020
Q4 | $1.44M | Buy |
12,289
+557
| +5% | +$61.3K | 1% | 26 |
|
|
2020
Q3 | $1.22M | Buy |
11,732
+9,415
| +406% | +$946K | 1.1% | 24 |
|
|
2020
Q2 | $211K | Buy |
2,317
+714
| +45% | +$68.5K | 0.22% | 89 |
|
|
2020
Q1 | $144K | Sell |
1,603
-5,715
| -78% | -$608K | 0.18% | 104 |
|
|
2019
Q4 | $830K | Sell |
7,318
-40
| -0.5% | -$4.39K | 0.57% | 58 |
|
|
2019
Q3 | $799K | Buy |
7,358
+631
| +9% | +$65.8K | 0.52% | 62 |
|
|
2019
Q2 | $655K | Buy |
6,727
+1,304
| +24% | +$119K | 0.44% | 65 |
|
|
2019
Q1 | $494K | Buy |
+5,423
| New | +$485K | 0.38% | 67 |
|
|
2018
Q3 | $569K | Buy |
5,782
+1,090
| +23% | +$101K | 0.27% | 95 |
|
|
2018
Q2 | $402K | Buy |
+4,692
| New | +$392K | 0.25% | 110 |
|
Other funds holding MDT
Truvestments Capital's MDT Position: Q2 2026 in Review
Truvestments Capital reduced its Medtronic (MDT) stake by 4.7% in Q2 2026, selling an estimated $38.6K and leaving 9,680 shares worth $757K. The position accounts for 0.11% of the portfolio, ranked #178.
Truvestments Capital first reported a position in MDT in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.84M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Truvestments Capital held 9,680 shares of Medtronic worth $757K as of Q2 2026.
- Truvestments Capital sold 478 Medtronic shares in Q2 2026, an estimated $38.6K.
- Medtronic made up 0.11% of Truvestments Capital's portfolio in Q2 2026, its #178 holding.
- Truvestments Capital first reported a position in Medtronic in Q2 2018 and has held it in 32 quarters since.
- Truvestments Capital's Medtronic position peaked at $2.84M in Q3 2024.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.